Sugen (SUGN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sugen (SUGN)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: scaram(o)uche	2/8/2005 9:28:15 AM
	of 550

Pfizer stomach-cancer drug succeeds in trial Tue Feb 8, 2005 09:16 AM ET NEW YORK, Feb 8 (Reuters) - Pfizer Inc. (PFE.N: Quote, Profile, Research) on Tuesday said a late-stage trial of its experimental drug for a deadly form of stomach cancer had been stopped prematurely after the medicine was shown to be safe and effective. The world's largest drugmaker said patients who had been receiving a dummy medicine in the trial now have the option of switching to the Pfizer drug, called SU11248, given its strong showing in the Phase III study. The medicine is being developed to treat patients with gastrointestinal stromal tumors, or GIST, who have failed to benefit from Novartis AG's (NOVN.VX: Quote, Profile, Research) Gleevec therapy.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next